Antares Pharma (AIS) Announces Successful Phase 2 for NES/E2 Utilizing ATD Gel System
Tweet Send to a Friend
Antares Pharma, Inc. (AMEX: AIS) and the Population Council today announced successful results from a dose-finding Phase 2 trial for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
